Company performance
Current Price
as of Jan 07, 2025$10.82
P/E Ratio
N/A
Market Cap
$1.73B
Loading...
Description
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Metrics
Overview
- HQGaithersburg, MD
- SectorHealth Technology
- IndustryBiotechnology
- TickerNVAX
- Price$10.82+10.86%
Trading Information
- Market cap$1.73B
- Float95.51%
- Average Daily Volume (1m)4,013,542
- Average Daily Volume (3m)5,282,184
- EPS-$2.16
Company
- Revenue$885.19M
- Rev growth (1yr)-54.80%
- Net income-$121.30M
- Gross margin30.40%
- EBITDA margin-138.53%
- EBITDA-$117.07M
- EV$1.33B
- EV/Revenue1.51
- P/EN/A
- P/S1.96
- P/BN/A
Documents
SEC Filings
Factset Street Account
Earnings Calls
Wikipedia